Lexicon Pharmaceuticals, Inc. (LXRX)
After hours:
| Previous Close | 1.8900 |
| Open | 1.8800 |
| Bid | 1.7700 x 2200 |
| Ask | 1.8200 x 700 |
| Day's Range | 1.7500 - 1.8950 |
| 52 Week Range | 0.9200 - 3.7300 |
| Volume | |
| Avg. Volume | 4,495,120 |
| Market Cap | 440.764M |
| Beta (5Y Monthly) | 1.38 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8300 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.25 |
GlobeNewswireLexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
THE WOODLANDS, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Bank of America Securities Healthcare Conference 2024. Jeff Wade, Lexicon’s president and chief financial officer, will make a company presentation on Tuesday, May 14, 2024, at 8:00 am PDT (11:00 am ET). A simultaneous webcast will be available in the “Events” section of the Lexicon website at www.lexpharma.com/events, and a recording of the webcast will be
Insider MonkeyLexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript May 5, 2024 Lexicon Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to the Lexicon Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At […]
- Thomson Reuters StreetEvents
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
